E-LIB Suche - Ergebnisse für: Choi, Goda

1

Relapse Incidence Post Unrelated Allogeneic Stem Cell Trans..:

Nagler Sr., Arnon ; Ngoya, Maud ; Galimard, Jacques-Emmanuel...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S46-S47 , 2024

Link: https://doi.org/10.1016/..

2

Comparable relapse incidence after unrelated allogeneic ste..:

Nagler, Arnon ; Ngoya, Maud ; Galimard, Jacques‐Emmanuel...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

3

Improved Outcome of Allogeneic Transplantation in Older Pat..:

Morsink, Linde M. ; Hazenberg, Carin L.E. ; Choi, Goda...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

4

HLA Mismatching and Transplant Outcome in the Ptcy Era: A C..:

Bolaños, Esteban Arrieta ; Bonneville, Edouard F ; Robin, Marie...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S21-S22 , 2024

Link: https://doi.org/10.1016/..

5

Donor KIR genotype based outcome prediction after allogenei..:

Schetelig, Johannes ; Baldauf, Henning ; Heidenreich, Falk...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

6

Allogeneic stem cell transplantation for patients with acut..:

Nagler, Arnon ; Labopin, Myriam ; Swoboda, Ryszard...
Bone Marrow Transplantation. 58 (2023) 5 - p. 552-557 , 2023

Link: https://doi.org/10.1038/..

7

Allogeneic hematopoietic cell transplantation for patients ..:

Maffini, Enrico ; Ngoya, Maud ; Galimard, Jacques-Emmanuel...
Bone Marrow Transplantation. 58 (2023) 9 - p. 1033-1041 , 2023

Link: https://doi.org/10.1038/..

8

Comparison of patellofemoral contact pressure after semi-cy..:

Choi, Goda ; Kang, Jinsu ; Kim, Namsoo.
Frontiers in Veterinary Science. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Clonal hematopoiesis in patients with stem cell mobilizatio..:

Hazenberg, Carin L. E. ; de Graaf, Aniek O. ; Mulder, René...
Blood Advances. 7 (2023) 7 - p. 1269-1278 , 2023

Link: https://doi.org/10.1182/..

10

Prediction of Nonrelapse Mortality in Patients With Acute M..:

Hermans, Sjoerd J. F. ; Versluis, Jurjen ; Labopin, Myriam...
HemaSphere. 7 (2023) 3 - p. e846 , 2023

Link: https://doi.org/10.1097/..

11

Impact of measurable residual disease on outcomes of unrela..:

Nagler, Arnon ; Labopin, Myriam ; Dholaria, Bhagirathbhai...
British Journal of Haematology. 201 (2023) 6 - p. 1169-1178 , 2023

Link: https://doi.org/10.1111/..

12

Impact of disease burden on clinical outcomes of AML patien..:

Abou Dalle, Iman ; Labopin, Myriam ; Kröger, Nicolaus...
Bone Marrow Transplantation. 58 (2023) 7 - p. 784-790 , 2023

Link: https://doi.org/10.1038/..

13

Integrating biological HLA-DPB1 mismatch models to predict ..:

Ruggeri, Annalisa ; De Wreede, Liesbeth C. ; Müller, Carlheinz R....
Haematologica. 108 (2022) 2 - p. 645-652 , 2022

Link: https://doi.org/10.3324/..

14

Should anti-thymocyte globulin be added in post-transplant ..:

Spyridonidis, Alexandros ; Labopin, Myriam ; Brissot, Eolia...
Bone Marrow Transplantation. 57 (2022) 12 - p. 1774-1780 , 2022

Link: https://doi.org/10.1038/..

15

Post-transplant cyclophosphamide in one-antigen mismatched ..:

Battipaglia, Giorgia ; Galimard, Jacques-Emmanuel ; Labopin, Myriam...
Bone Marrow Transplantation. 57 (2022) 4 - p. 562-571 , 2022

Link: https://doi.org/10.1038/..